GoodRx reports men in D.C. fill hair-loss prescriptions over five times the national average, highlighting geographic disparities in treatment.
Using a professional-grade and gel-powered formulation, Lee's Callus Remover instantly transforms rough, cracked and ...
Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...
AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability
AH-001 is a novel, AI-designed small molecule that works through a targeted protein degradation mechanism to selectively ...
AbbVie on Wednesday said the replicate Phase 3 studies met their co-primary endpoints of reduction in de-pigmentation over the entire body and the face in adults and adolescents with non-segmental ...
Producer Robyn Meisinger’s Hermosa Beach wedding ditched gifts to fund wigs for girls battling alopecia and cancer.
Dermatologic side effects from breast cancer treatments include chemotherapy-induced allergic reactions and drug-specific effects like hand-foot syndrome, and immunotherapy-related immune skin ...
More than half of adolescents treated with baricitinib achieved complete or near-complete scalp hair regrowth at 1 year, with ...
Researchers suggest that stevioside, a compound from the stevia plant, could enhance hair-loss therapies by improving ...
The ALPHAMEDIX-02 trial assessed 212Pb-DOTAMTATE in PRRT-naïve and PRRT-exposed GEP-NET patients, showing promising efficacy in both cohorts. PRRT-naïve patients exhibited a 60% response rate, while ...
Forte Biosciences Inc. (($FBRX)) announced an update on their ongoing clinical study. Forte Biosciences Inc. is conducting a study titled ‘A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback